Reviva Pharmaceuticals Announces Completion of Patient Enrollment in Phase …
Reviva Pharmaceuticals Announces Completion of Patient Enrollment in Phase …
Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder. … Reviva … Read more on PharmiWeb.com (press release)
LA Kings' Kopitar back on ice with knee injury
EL SEGUNDO, Calif.—Anze Kopitar skated at the Los Angeles Kings' training complex Monday with a brace on his sprained right knee, reporting no problems in his comeback from the recent injury. The Kings' high-scoring center still is unlikely to play in … Read more on Contra Costa Times
Tags: treatment of schizophrenia, patient enrollment, clinical trial, los angeles kings, anze kopitar